Vericel Corp. (VCEL)
37.38
+0.35
(+0.95%)
USD |
NASDAQ |
Jun 10, 16:00
37.44
+0.06
(+0.16%)
Pre-Market: 20:00
Vericel Market Cap : 1.907B for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 1.907B |
| June 09, 2026 | 1.889B |
| June 08, 2026 | 1.825B |
| June 05, 2026 | 1.852B |
| June 04, 2026 | 1.821B |
| June 03, 2026 | 1.772B |
| June 02, 2026 | 1.757B |
| June 01, 2026 | 1.674B |
| May 29, 2026 | 1.700B |
| May 28, 2026 | 1.747B |
| May 27, 2026 | 1.750B |
| May 26, 2026 | 1.786B |
| May 22, 2026 | 1.774B |
| May 21, 2026 | 1.795B |
| May 20, 2026 | 1.808B |
| May 19, 2026 | 1.761B |
| May 18, 2026 | 1.781B |
| May 15, 2026 | 1.687B |
| May 14, 2026 | 1.692B |
| May 13, 2026 | 1.677B |
| May 12, 2026 | 1.682B |
| May 11, 2026 | 1.681B |
| May 08, 2026 | 1.709B |
| May 07, 2026 | 1.794B |
| May 06, 2026 | 1.878B |
| Date | Value |
|---|---|
| May 05, 2026 | 1.880B |
| May 04, 2026 | 1.863B |
| May 01, 2026 | 1.806B |
| April 30, 2026 | 1.763B |
| April 29, 2026 | 1.697B |
| April 28, 2026 | 1.810B |
| April 27, 2026 | 1.874B |
| April 24, 2026 | 1.809B |
| April 23, 2026 | 1.746B |
| April 22, 2026 | 1.745B |
| April 21, 2026 | 1.709B |
| April 20, 2026 | 1.818B |
| April 17, 2026 | 1.811B |
| April 16, 2026 | 1.714B |
| April 15, 2026 | 1.795B |
| April 14, 2026 | 1.784B |
| April 13, 2026 | 1.748B |
| April 10, 2026 | 1.711B |
| April 09, 2026 | 1.705B |
| April 08, 2026 | 1.727B |
| April 07, 2026 | 1.692B |
| April 06, 2026 | 1.730B |
| April 02, 2026 | 1.733B |
| April 01, 2026 | 1.653B |
| March 31, 2026 | 1.633B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Marker Therapeutics, Inc. | 23.84M |
| Krystal Biotech, Inc. | 9.196B |
| TG Therapeutics, Inc. | 7.137B |
| Gyre Therapeutics, Inc. | 543.46M |
| ACADIA Pharmaceuticals, Inc. | 3.636B |
Market Cap Related Metrics
| PE Ratio | 91.37 |
| PS Ratio | 6.563 |
| PEG Ratio | 0.0974 |
| Price to Book Value | 5.353 |
| Price to Free Cash Flow | 40.37 |
| Price | 37.38 |
| Earnings Yield | 1.09% |
| PEGY Ratio | 0.0974 |
| Operating PE Ratio | 121.53 |
| Normalized PE Ratio | 91.39 |